Abstract: In an electric vehicle having a plurality of MG units each including an AC motor and an inverter, a control apparatus executes system voltage stabilization control to suppress variations in a system voltage by adjusting an input power of a first MG unit or a second MG unit so as to reduce the difference between a target value and detected value of the system voltage. In execution of this control, either one or both of the MG units is selected by a selector by using information on the first MG unit and the second MG unit. The system voltage stabilization control is executed on the selected MG unit. Alternatively, the control apparatus may execute the system voltage stabilization control by selecting a voltage boosting converter.

Abstract: A control apparatus for a vehicle controls the input power of an AC motor to reduce the difference between a target value and detected value of the system voltage. When a rotation speed of the AC motor increases to be higher than a predetermined value or when a command value of a torque generated by the AC motor increases to be greater than a predetermined value, a current vector is adjusted to a value on a lagging side in order to control the input power of the AC motor. Thus, an input power operation quantity required for stabilizing the system voltage can be realized with a high degree of reliability. When the rotation speed and the command value decrease, the current vector is adjusted to a value on a leading side in order to control the input power of the AC motor.

Abstract: In a control apparatus for an electric vehicle, an input power operation quantity that reduces the difference between a target value of a system voltage and a detected value of the voltage is computed, and a duty ratio of a rectangular waveform applied to an inverter is set at a value that changes the input power of a MG unit by the input power operation quantity. The phase of the rectangular waveform is set at a value that suppresses torque variations caused by the duty ratio as variations of a torque generated by the AC motor. 3-phase voltage command signals are computed on the basis of the phase and the duty ratio and supplied to the inverter. In this way, variations in system voltage can be suppressed by controlling the input power of the AC motor, while sustaining the torque generated by the AC motor unchanged.

Abstract: In electric vehicle control, system voltage stabilization control is executed to reduce the difference between a target value and detected value of a system voltage generated by a voltage boosting converter for an AC motor. Further, conversion power control is executed to reduce the difference between a command value and detected value of the conversion power, which is defined as the output power of the voltage boosting converter. A conversion power correction quantity is computed from an input power operation quantity of the system voltage stabilization control and reflected in the conversion power control to correct the conversion power. Thus, variations in a system voltage caused by an error or the conversion power control can be reduced.

Abstract: In electric vehicle control, system voltage stabilization control is executed to reduce the difference between a target value and detected value of a system voltage generated by a voltage boosting converter for an AC motor. Further, conversion power control is executed to reduce the difference between a command value and detected value of the conversion power, which is defined as the output power of the voltage boosting converter. Thus, variations in a system voltage caused by an error or the conversion power control can be reduced.

Abstract: A vehicle-supervising electronic control unit (VS-ECU) measures driving torque, which is outputted from an engine to a drive shaft through an automatic transmission. The VS-ECU measures road surface transmission torque based on rotation speeds of driving wheels of a vehicle, vehicle body speed and driving wheel torque, which are measured in advance. The VS-ECU compares the driving torque with the road surface transmission torque. If it is determined that the driving torque is greater than the road surface transmission torque, the VS-ECU estimates an opening degree of an air bypass valve for controlling the driving torque so that a difference between the driving torque and the road surface transmission torque is decreased.

Abstract: Disclosed is a multi-layer film comprising: a surface layer having a thickness of 10 to 50 ƒÊm made of an ethylene-ƒ-olefin copolymer halving a density of 0.935 to 0.950 g/cm3, a flexible layer having a thickness of 100 to 200 ƒÊm made of an ethylene-ƒ-olefin copolymer having a density of 0.860 to 0.930 g/cm3, a barrier layer having a thickness of 10 to 80 ƒÊm made of a mixed resin containing 60 to 95% by weight of a cyclic olefin polymer and 5 to 40% by weight of an ethylene-ƒ-olefin copolymer having a density of 0.900 to 0.965 g/cm3, and a seal layer having a thickness of 5 to 80 ƒÊm made of an ethylene-ƒ-olefin copolymer having a density or 0.910 to 0.950 g/cm3. This multi-layer film is suited for use as a material for production of a medicine container 10 because it suppresses adsorption of a medicine by the barrier layer and is also superior in strength and flexibility.

Abstract: A multiple-chamber medical container 1 comprises a container body 5 having two chambers 9, 11 for containing medicaments therein and a partitioning weak seal portion 13 for separating the chambers 9, 11 from each other, a medicinal outlet portion 7 attached to the container body 5 for discharging the medicaments from the chambers therethrough, and an openable small container 15 disposed in the first chamber 9 and having a medicament enclosed therein, the partitioning seal portion 15 being openable so as to cause the chambers 9, 11 to communicate with each other for use. The small container 15 can be opened by opening the partitioning weak seal portion 13.

Abstract: A vehicle-supervising electronic control unit (VS-ECU) measures driving torque, which is outputted from an engine to a drive shaft through an automatic transmission. The VS-ECU measures road surface transmission torque based on rotation speeds of driving wheels of a vehicle, vehicle body speed and driving wheel torque, which are measured in advance. The VS-ECU compares the driving torque with the road surface transmission torque. If it is determined that the driving torque is greater than the road surface transmission torque, the VS-ECU estimates an opening degree of an air bypass valve for controlling the driving torque so that a difference between the driving torque and the road surface transmission torque is decreased.

Abstract: Addition of a cyclodextrin compound to the cilostazol aqueous pharmaceutical preparation for parenteral use which comprises cilostazol or a pharmacologically acceptable salt thereof as an active ingredient can increase water solubility of cilostazol or a pharmacologically acceptable salt thereof, giving an aqueous pharmaceutical preparation for parenteral use of cilostazol or a pharmacologically acceptable salt thereof, of which the stability with time in the liquid state is improved.

Abstract: The invention provides a reducing sugar-containing fat emulsion comprising an oil-in-water fat emulsion available upon emulsification of a fat with an emulsifier wherein a reducing sugar and at least one buffer substance selected from among organic acids with acid dissociation exponents in water within the range of 5.0-7.5 and their salts are concurrently contained in the water phase thereof, with the emulsion having been adjusted to pH 5.0-7.5; a reducing sugar-containing fat emulsion product which comprises a medicinal fluid containing a reducing sugar and a fat as sterilized with carbon dioxide gas dissolved therein and contained in a plastic infusion container, said plastic infusion container being accommodated together with a carbon dioxide gas absorber in a substantially oxygen-impermeable secondary container; and a method for their preparation and sterilization.

Abstract: The invention relates to a bicarbonate-containing medical solution package. The package comprises a gas-permeable plastic container holding a bicarbonate-containing medical solution and a gas-impermeable plastic packaging member containing the gas-permeable plastic container. A carbon-dioxide atmosphere is established in the space between the container and packaging member. In addition, a pH indicating device is contained within the space between the container and packaging member. The pH indicating device is a gas-permeable plastic packet containing a bicarbonate-containing fluid (similar to the medical solution) and a pH indicator. The pH indicator undergoes a change in color in response to a change in pH of the fluid. Use of this package allows the easy monitoring of a change in pH and consequent aging of the medical solution due to prolonged storage or damage to the outer packaging member.

Abstract: A composition for a ceramic substrate comprising from 30 to 70% by weight of glass powder, from 28 to 70% by weight of refractory filler powder and an oxidizing agent, said glass powder consisting essentially of from 38 to 48% by weight of SiO.sub.2, from 1 to 8% by weight of Al.sub.2 O.sub.3, from 0 to 10% by weight of MgO, from 18 to 28% by weight of BaO, from 1 to 8% by weight of CaO, from 0 to 15% by weight of SrO, from 0.5 to 15% by weight of B.sub.2 O.sub.3, from 0 to 20% by weight of PbO, from 10 to 20% by weight of ZnO, from 0 to 7% by weight of TiO.sub.2 plus ZrO.sub.2 and from 0 to 5% by weight of Li.sub.2 O plus Na.sub.2 O plus K.sub.2 O, and said refractory filler powder comprising from 20 to 60% by weight of alumina, from 0 to 40% by weight of zircon, from 0 to 30% by weight of cordierite and from 0 to 30% by weight of forsterite.

Abstract: A composition for a ceramic substrate comprising from 30 to 70% by weight of glass powder, from 28 to 70% by weight of refractory filler powder and an oxidizing agent, said glass powder consisting essentially of from 38 to 48% by weight of SiO.sub.2, from 1 to 8% by weight of Al.sub.2 O.sub.3, from 0 to 10% by weight of MgO, from 18 to 28% by weight of BaO, from 1 to 8% by weight of CaO, from 0 to 15% by weight of SrO, from 0.5 to 15% by weight of B.sub.2 O.sub.3, from 0 to 20% by weight of PbO, from 10 to 20% by weight of ZnO, from 0 to 7% by weight of TiO.sub.2 plus ZrO.sub.2 and from 0 to 5% by weight of Li.sub.2 O plus Na.sub.2 O plus K.sub.2 O, and said refractory filler powder comprising from 20 to 60% by weight of alumina, from 0 to 40% by weight of zircon, from 0 to 30% by weight of cordierite and from 0 to 30% by weight of forsterite.